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Wound healing is a complex process regulated by multiple signals and consisting of several phases known as haemostasis,
inflammation, proliferation, and remodelling. Keratinocytes, endothelial cells, macrophages, and fibroblasts are the major cell
populations involved in wound healing process. Hypoxia plays a critical role in this process since cells sense and respond to
hypoxic conditions by changing gene expression. This study assessed the in vitro expression of 77 genes involved in angiogenesis,
metabolism, cell growth, proliferation and apoptosis in human keratinocytes (HaCaT), microvascular endothelial cells (HMEC-1),
differentiated macrophages (THP-1), and dermal fibroblasts (HDF). Results indicated that the gene expression profiles induced by
hypoxia were cell-type specific. In HMEC-1 and differentiated THP-1, most of the genes modulated by hypoxia encode proteins
involved in angiogenesis or belonging to cytokines and growth factors. In HaCaT and HDF, hypoxia mainly affected the expression
of genes encoding proteins involved in cell metabolism.This work can help to enlarge the current knowledge about themechanisms
through which a hypoxic environment influences wound healing processes at the molecular level.
1. Introduction
Wound healing is a complex multistep and multicellular
biological process, traditionally divided into four overlapping
phases known as haemostasis, inflammation, proliferation,
and remodelling [1]. Inflammation and hypoxia are mutually
interdependent: hypoxia-elicited inflammation is implicated
in the outcomes of a wide range of human diseases. The delay
in wound healing and wound chronicity are directly linked
to persistent inflammation. On the other hand, inflammatory
states are frequently characterised by tissue hypoxia, or by
the stabilisation of hypoxia-dependent transcription factors
[2, 3]. The healing process is regulated by multiple signals
such as growth factors, cytokines, chemokines, matrix met-
alloproteinases (MMPs) and extracellular macromolecules
[4, 5]. Upon skin injury, innate immune cells (neutrophils and
macrophages) are recruited to the site of injury to remove
cellular debris and to secrete mediators able to activate
keratinocytes, endothelial cells and fibroblasts. Angiogenesis
is crucial to ensure an adequate supply of blood for tissue
repair and wound healing [6]. Endothelial cells proliferate,
demolish basement membrane and migrate to form new
blood vessels starting from the ones located at wound
edges. Fibroblasts produce collagen, elastin, proteoglycans
and other glycoproteins of the extracellular matrix, which
then mature outside the cells. Some fibroblasts develop
into myofibroblasts that cause contraction of the wound.
Keratinocytes proliferate and migrate from the edges of the
wound to restore a confluent epithelium. Migration and
proliferation of all the cell types is regulated by complex
mechanisms of inhibition and stimulation by growth factors
and chemoattractants.
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Keratinocytes, endothelial cells, macrophages and fibrob-
lasts are indeed the major cell populations involved in
wound healing processes and all of these cells cross-talk
with one another to restore normal tissue [7]. Oxygen is a
key regulator of ordered wound healing since it is required
for epithelialisation, angiogenesis, collagen deposition, and
resistance to infection [8]. Hypoxia in wound is mainly
caused by the disruption of blood vasculature causing impair-
ment of oxygen delivery to the site of injury. Moreover,
the rapid recruitment of inflammatory cells increases oxy-
gen demand to achieve phagocytosis and microbial killing.
Reduced oxygen supply leads to chronic hypoxia along with
inadequate healing or chronic wounds. Cells sense hypoxia
and can alter gene expression changing their metabolism in
order to promote cell survival. The transcriptional response
is mainly mediated by hypoxia-inducible factor 1 (HIF-1)
which regulates the transcription of hundreds of genes that
promote cell survival in hypoxia. Different genes involved in
regulation of metabolism, cell proliferation and angiogenesis
are modulated by hypoxia, but gene expression profiles in
response to hypoxia differ among different cell populations.
This study aimed at assessing the gene expression re-
sponses to hypoxia in four different cell types involved in
wound healing. In particular, cell processes/functions rele-
vant for wound healing, namely angiogenesis, metabolism,
cell growth and proliferation, apoptosis, transcription and
signalling, were identified. The expression of 77 genes
involved in these processes were explored in vitro, using cell
models of keratinocytes, endothelial cells, macrophages, and
fibroblasts.
This study, addressing the cell-specific responses to
hypoxia, may help to better understand the regulation of gene
expression profile in different cell populations, and it may
provide insight on the role of hypoxia in wound healing.
2. Materials and Methods
2.1. Reagents. All reagents were from Sigma Aldrich S.r.l.
(Milano, Italy), unless otherwise stated. All reagents for cell
culture were from EuroClone S.p.A (Pero, Italy), unless oth-
erwise stated. All reagents for RT-qPCR were from QIAGEN
S.r.l. (Milano, Italy), unless otherwise stated.
2.2. Cells Cultures. HMEC-1, a long-term cell line of dermal
microvascular endothelial cells (HMEC-1) immortalised by
SV 40 large T antigen [9], was maintained in MCDB-131
medium (Invitrogen, Carlsbad, CA) supplemented with 10%
heat-inactivated foetal calf serum (FCS) (HyClone, South
Logan, UT), 10 ng/ml of epidermal growth factor (PeproTech,
Rocky Hill, NJ), 1𝜇g/ml of hydrocortisone, 2mM glutamine,
100 units/ml of penicillin, 100𝜇g/ml of streptomycin, and
20mMHEPES buffer, pH7.4.
THP-1 cells (human acute monocytic leukaemia cell line)
were maintained in RPMI supplemented with 10% heat-
inactivated FCS, 50 𝜇M 2-mercaptoethanol, 10 𝜇M Sodium
Pyruvate, 20mM HEPES, and 2mM glutamine. In order to
achieve differentiation into macrophages, cells were treated
with 10 ng/ml phorbol myristate acetate (PMA) for 72 h.
HaCaT (CVCL-0038, Cell Line Service GmbH, Ger-
many), a spontaneously transformed immortal keratinocyte
cell line from adult human skin, were maintained in DMEM
supplemented with 10% heat-inactivated FCS, 100 U/ml
penicillin-streptomycin (GibcoTM, Life Technologies Italia,
Monza, Italy), 2mM L-glutamine (Life Technologies Italia,
Monza, Italy).
HDF, normal adult human primary dermal fibroblasts,
were maintained in DMEM supplemented with 10% heat-
inactivated FCS, 100 U/ml penicillin-streptomycin (Life
Technologies, Italy), and 2mMglutamine (Life Technologies,
Italy).
All the cell lines were cultured in standard conditions, at
37∘C in a humidified atmosphere containing 5% CO
2
.
2.3. Cell Treatment. HMEC-1 were seeded at 2∗105 cells/well
in 6-well flat bottom tissue culture clusters and incubated
for 72 hours to obtain adhesion to the plastic. THP-1 were
seeded at 5∗105 cells/well in 24-well flat bottom tissue culture
clusters and incubated with PMA (10 ng/ml) for 72 hours
to achieve differentiation into macrophages. HaCaT were
seeded at 6∗104 cells/well in 24-well flat bottom tissue culture
clusters and incubated for 72 hours. HDF were seeded at
12∗104 cells/well in 24-well flat bottom tissue culture clusters
and incubated for 72 hours.
Cells were then incubated for 24 hours in hypoxic or nor-
moxic condition. A Hypoxia Incubator Chamber (StemCells
Technologies) was filled with a gas mixture consisting of 1%
O
2
, 5% CO
2
, 94% N
2
for 5 minutes at a rate of 10 L/min to
achieve hypoxia, according to an established protocol which
was previously shown to induce HIF-1 activation in cells
[10]. At the end of incubation, mRNA from cell cultures was
isolated.
2.4. RNA Extraction. Samples (10∧6 cells) were lysed in QIA-
zol lysis reagent. Total RNA was extracted from cell lysates
using the miRNeasy Mini Kit following the manufacturer’s
protocol. A set of RNase free DNase was used to provide
efficient on-column digestion of genomic DNA. Total RNAs
were eluted in 35𝜇Lnuclease-free water.TheRNAconcentra-
tion and quality were assessed using the NanoDrop ND-1000
spectrophotometer (Thermo Fisher Scientific Italia, Rodano,
Italy). Sample purity was estimated by measuring A260/280
and A260/230 ratios of spectrophotometric absorbance to
check for possible copurified contaminants during the RNA
isolation.
2.5. RT-qPCR. cDNA synthesis and genomic DNA elimina-
tion were performed with the RT2 First Strand Kit, using
400 ng of total RNA for each sample. Samples were quantified
using Custom RT2 Profiler PCR Arrays (QIAGEN) by real-
time PCR using a CFX384 real-time system instrument (Bio-
Rad Laboratories S.r.l., Segrate, Italy) with the RT2 SYBR
Green qPCR Mastermix. The manufacturer’s instructions
were strictly followed.
Expression data were normalised to the housekeeping
gene RPLP0 (Ribosomal Protein Lateral Stalk Subunit P0).
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Figure 1: Hypoxia effect on cell viability. HaCaT, HDF, HMEC-1 and differentiated THP-1 were incubated for 24 h in normoxia (black bars)
or hypoxia (1% O2, gray bars). The percentage of cell viability was measured using the MTT assay (panel (a)), whereas the percentage of
cytotoxicity was calculated measuring the release of LDH (panel (b)). Data are shown as mean ± standard deviation of three independent
experiments. Two-tailed Student’s t-test was performed to compare viability and cytotoxicity in normoxia vs hypoxia.
The relative quantification in gene expressionwas determined
using a modified ΔΔCt method based on Pfaffl equation [11].
2.6. Cytotoxicity and Viability Assays. HMEC-1 was seeded
at 104 cells/well in 96-well flat bottom tissue culture clusters
and incubated overnight to obtain adhesion to the plastic.
THP-1 were seeded at 105 cells/well in 96-well flat bottom
tissue culture clusters and incubated with PMA (10 ng/ml)
for 72 hours to achieve differentiation into macrophages.
HaCaT were seeded at 6∗104 cells/well in 24-well flat bottom
tissue culture clusters and incubated for 72 hours. HDF were
seeded at 12∗104 cells/well in 24-well flat bottom tissue culture
clusters and incubated for 72 hours. Cellswere then incubated
for 24 hours in hypoxic or normoxic condition as described
above.
2.7. MTT Assay. Cell viability was evaluated using the 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay. After incubation of cells in normoxic or hypoxic
conditions, 10% V/V of a 5mg/mL solution of MTT in
PBS were added to the cells for 3 hours at 37∘C in the
dark. The supernatants were then discarded, and the dark
blue formazan crystals dissolved using 100𝜇L of lysis buffer
containing 20% (w/V) sodium dodecylsulfate, 40% N, N-
dimethylformamide (pH 4.7 in 80% acetic acid). The plates
were then read on a Synergy 4 (Biotek) microplate reader at
a test wavelength of 550 nm and at a reference wavelength of
650 nm.
2.8. LDH Assay. The potential cytotoxic effect of hypoxia
was measured as the release of lactate dehydrogenase (LDH)
from cells into the extracellular medium using the LDH-
Cytotoxicity Colorimetric Assay Kit II (BioVision, Segrate,
Italia) following the manufacturer’s instructions. LDH was
measured both in the extracellular medium and inside the
cells. Tomeasure the extracellular LDH, 10 𝜇L of supernatants
were mixed with 100 𝜇L of LDH reaction mix. To measure
intracellular LDH, 10 𝜇L of Cell Lysis Solution were added to
the wells and 11𝜇L of the lysate were mixed with 100𝜇L of
LDH reaction mix. Samples were incubated for 30 minutes
at room temperature in the dark. Absorbance was then read
at 450 nm with a reference wavelength of 650 nm using
Synergy 4 (Biotek) microplate reader. Percent cytotoxicity
was calculated following the equation modified by Smith [12].
2.9. Statistical Analysis. All data were obtained from at least
three independent experiments. Results are shown as means
± standard deviation. Differences between normoxia and
hypoxia were analysed by two-tailed Student’s t-test.
3. Results and Discussion
3.1. Effect of Hypoxia on Cell Viability. Cells were incubated
in hypoxic condition for 24 hours and viability was measured
by MTT and LDH assays. A direct toxicity was not observed
since cytotoxicity, measured as the release of LDH from cell
monolayers, or viability, measured asMTTmetabolism, were
comparable in hypoxic and normoxic conditions in all the cell
types (Figure 1). Cell morphology was not macroscopically
altered by hypoxia.
3.2. Effect of Hypoxia on Gene Expression. In response to
hypoxia, cells undergo a metabolic reprogramming orches-
trated by hypoxia-inducible factors (HIFs) which translocate
to the nucleus and activate the transcription of hundreds
of target genes. Nevertheless, the transcriptional program in
response to a hypoxic challenge extensively varies among
different cell types [13, 14].
In this work, the gene expression program in response
to hypoxia in cell types involved in wound healing was
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characterised. The expression of 77 genes was measured
by RT-qPCR after 24 h of cell exposure to hypoxia. The
transcript levels for each gene in cells cultured under
hypoxia (1% O
2
) were compared to the transcript levels
in the same cell type cultured in normoxic conditions (∼
21% O
2
). Seven common genes induced by hypoxia in all
the tested cells were identified. These common upregulated
genes encode proteins involved in glycolytic metabolism
(TPI1, Triosephosphate isomerase 1; HK2, hexokinase 2), cell
proliferation and apoptosis (BNIP3, BCL2 Interacting Protein
3), angiogenesis (VEGFA, Vascular endothelial growth factor
A; ANGPTL4, Angiopoietin like 4), or transcription and sig-
nalling (ANKRD37, Ankyrin Repeat Domain 37; BHLHE4,
Basic Helix-Loop-Helix family member e40). Among the
selected genes, only few were downregulated and none was
downregulated in all the four cell lines.
The expression of 14 genes was not significantly modu-
lated by hypoxia in any tested cell types. These genes encode
chemokines and cytokines (CCL11, C-C Motif Chemokine
Ligand 11; CXCL1, C-X-C Motif Chemokine Ligand 1;
CXCL10, C-X-C Motif Chemokine Ligand 10; CXCL5, C-X-
C Motif Chemokine Ligand 5), growth factors and receptors
(EGF, Epidermal Growth factor; FGF1, Fibroblast Growth
Factor 1; IGF1, Insulin Like Growth Factor 1; ERBB2, Erb-B2
Receptor Tyrosine Kinase 2; S1PR1, Sphingosine-1-phosphate
receptor 1), transcription and signalling factors (HNF4A,
Hepatocyte Nuclear Factor 4 Alpha; ID1, Inhibitor of DNA
binding 1, HLH protein), as well as proteins involved in
angiogenesis (COL18A1, Collagen type XVIII alpha 1 chains;
LECT1, chondromodulin) and coagulation (THBS2, Throm-
bospondin 2).
Two genes CXCL9 (C-X-C Motif Chemokine Ligand 9)
and IFNG (Interferon Gamma) were not expressed in either
cell type.
Depending on the cell types, a different number of genes
were up- or downregulated. The detailed number of hypoxia-
regulated genes in each cell types are shown in Figure 2. Raw
data are presented in Supplementary Table1.
Then we focus on specific sets of hypoxia-regulated
genes, depending on the function of the encoded protein.
Groups were labeled “angiogenesis”, “apoptosis/cell cycle”,
“cytokines/chemokines”, “growth factors/receptors”, “coag-
ulation”, “transcription/signaling factors”, “glycolytic metab-
olism”, “non-glycolytic metabolism”. However, the wound
healing process involves complex interactions between angio-
genesis, inflammation, coagulation and extracellular matrix
deposition; therefore some genes included in a given set may
be also relevant in others processes.
3.3. Angiogenesis. The expression of 16 genes coding proteins
strictly involved in angiogenesis was analysed (Figure 3). Two
genes (MMP2, Matrix Metallopeptidase 2 and CDH5, VE-
cadherin) were significantly up-regulated by hypoxia only
in HMEC-1, whereas COL4A3 and LEP were specifically
increased in THP-1 and HDF, respectively.
VEGF-A is produced by many cell types involved in
wound healing, and it plays a key role not only in angiogen-
esis, but also in epithelisation and collagen deposition [15].
HaCaT HDF HMEC-1 THP-1
Upregulated
Downregulated
36
0
23 23
44
36
5
0
5
10
15
20
25
30
35
40
N
um
be
r o
f g
en
es
Figure 2: Regulation of gene expression.HaCaT,HDF,HMEC-1 and
THP-1 were incubated for 24 h in normoxia or hypoxia. Histograms
represent the number of genes significantly up-regulated (black
bars) or downregulated (grey bars) in each cell type.
VEGF-A induces endothelial cell proliferation and migration
stimulating chemotaxis and vasodilatation. VEGFA gene
expression is increased by hypoxia in different cell types [15]
and, as expected, it was upregulated in all the cell lines used
in this work. ANGPTL4, the other gene up-regulated in all
the cells tested, is induced by HIF-1𝛼 in hypoxic conditions
[16]. ANGPTL4 encodes Angiopoietin Like 4, a secreted
factor belonging to a superfamily of proteins implicated
in the regulation of metabolism, inflammation and angio-
genesis [17]. Angiopoietin Like 4 improves angiogenesis by
disrupting the integrity of vascular junctions and by inducing
vascular leakage and plays an important role in wound repair
[18, 19]. Our data indicate that under hypoxia all the cells
implicated in wound healing participate in the induction
of both VEGFA and ANGPTL4 to accelerate wound repair
(Figure 3).
Most of the analysed genes are involved in extracellular
matrix deposition and remodelling. The balance between
matrix metalloproteinases (MMPs) and their inhibitors (tis-
sue inhibitors of metalloproteinases, TIMPs) is a key process
in wound healing. Hypoxia increased the expression of
MMP2 in HMEC-1 (Figure 3(c)) and of MMP9 in HaCaT
and THP-1 (Figures 3(a) and 3(d)). The enhanced expression
of MMP2 is consistent with previous studies describing the
induction of MMP-2 protein levels and activity in HMEC-
1 by hypoxia [20], but in contrast with the downregulation
observed by Loboda and colleagues using macroarray analy-
sis [21]. The modulation of MMP-9 in keratinocytes cultured
in hypoxia is controversial: MMP-9 is increased by hypoxia
in human keratinocytes [22] but decreased in HaCaT [23].
Xia and colleagues have proposed that hypoxia-dependent
regulation of MMP production varies depending on the
donor’s age [24]. Interestingly, both MMP9 and TIMP1 were
upregulated in differentiated THP-1, indicating that hypoxia
induces a coordinated mechanism able to activate matrix
degradation and to prevent excessive proteolysis at the same
time. COL18A1 and COL4A3 encode chains of XVIII and IV
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Figure 3: RT-qPCR analysis of genes involved in angiogenesis after 24 hours of incubation in normoxia or hypoxia in HaCaT (a), HDF (b),
HMEC-1 (c) and THP-1 (d). The results are expressed as Ct after normalization on RPLP0 housekeeping gene. Data are shown as mean
± standard deviation and as single values distribution of four independent experiments. Circles (e) and triangles (󳶃) represent Ct values
in normoxia and hypoxia, respectively. Statistical analysis was performed using the two-tailed Student’s t-test comparing, for each gene, the
expression in hypoxia versus normoxia (∗p-value < 0,05; ∗∗ p-value < 0,01; ∗ ∗ ∗p-value < 0,001).
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collagen types. Hypoxia did not modulate their expression
except for COL4A3, which was significantly up-regulated
in THP-1 (Figure 3(d)). Although macrophages are mostly
involved in matrix degradation, their ability to express all
collagen mRNA was described [25]. The cross-linking of
collagens is catalysed by lysyl oxidases [26, 27], extracellular
copper enzymes. Lysyl oxidase (LOX) is a hypoxia-responsive
factor associated with the malignant progression of carci-
noma [28]. In our work, hypoxia induced an increase of the
LOX gene expression in HMEC-1 and HaCaT, although in
the latter cell line the expression level was low (Figures 3(a)
and 3(c)). Increased expression of P4HA1, encoding one of
the isoforms of collagen prolyl 4-hydroxylases (P4Hs), was
observed in all cell types except for HDF (Figure 3). This
enzyme is involved in the biogenesis of collagen into stable,
mature, triple helical form [29]. Previous studies have shown
that the expression of P4HA1 mRNAs is increased under
hypoxic conditions in various cell types [30, 31]. Altogether,
these data confirm and expand knowledge on the role of
hypoxia in matrix remodeling during wound healing process
[32].
ADM (adrenomedullin) is an autocrine and paracrine
vasoactive peptide with hypotensive and immune-
modulating activity [33] able to promote angiogenesis
by inducing proliferation and migration of endothelial cells
[34]. ADM gene is a HIF-responsive gene [35] in a variety
of cell lines, including HMEC-1 [36]. Here, ADM expression
was enhanced in all cell types except for HDF (Figure 3).
Low level expression of LEP (leptin) gene was observed
in all the cell types except HDF, where the expression was
increased by hypoxia (Figure 3). The LEP gene encodes
a protein that is secreted by white adipocytes into the
circulation and plays a major role in the regulation of energy
homeostasis. This protein also has endocrine functions and
is involved in the regulation of immune and inflammatory
responses, haematopoiesis, angiogenesis, reproduction, bone
formation and wound healing [37, 38].
CDH5 and NOS3 genes are specifically expressed in
endothelium. CDH5 encodes VE-cadherin, one of the most
important cell junction proteins involved in vessel organiza-
tion [39]. VE-cadherin is also expressed in tumours, where
it is induced by hypoxia [40]. In our endothelial model
CDH5 is significantly increased by hypoxia, consistently
with previous data [21]. NOS3 encodes endothelial nitric-
oxide synthase (eNOS), an enzyme constitutively expressed
in endothelial cells. Among those analysed in this work,
it is one of the few genes significantly downregulated in
HMEC-1 upon 24h hypoxia (Figure 3(c)). Also the orphan
receptor TIE1 (tyrosine kinase with immunoglobulin like
and EGF like domains 1) is specific of endothelial cells. It
is involved in angiogenesis since it inhibits angiopoietin 1
signaling interacting with the endothelial receptor tyrosine
kinase Tie2. TIE1 was significantly increased by hypoxia only
in THP-1 (Figure 3(d)).
PROK2 encodes prokineticin 2, which is increased in
wound healing as demonstrated in human skin biopsies
[41]. However, in our model PROK2 was expressed only
in differentiated THP-1 where it was increased by hypoxia
(Figure 3(d)). The lack of PROK2 expression in the other cell
types may indicate that the induction of this gene requires
other stimuli such as cell-cell interactions.
LECT1 is not relevant to the skin model, since it encodes
Chondromodulin, which promotes chondrocyte growth and
inhibits angiogenesis in cartilage [42]. LECT1 was not
expressed in HMEC-1. In the other three cell types, LECT1
was expressed at low level and not modulated by hypoxia
(Figure 3).
3.4. Apoptosis and Cell Cycle. Usually, severe and prolonged
hypoxia can induce apoptosis, whereas mild hypoxia (oxygen
levels above 0.5%) prevents cells from undergoing apoptosis
[43]. Under hypoxia, cells can arrest cell cycle at the G
1
/S
interface [44] and several genes can be expressed to promote
cell surviving. Moreover, hypoxia can reduce the sensitivity
of cells to apoptotic stimuli [45]. Complex mechanisms
stimulate the production of both pro- and antiapoptotic
factors but also of factors that induce cell proliferation.
Our data clearly show that hypoxia significantly affected the
expression of genes involved in apoptosis and cell growth
(Figure 4). In particular, hypoxia induced both proapoptotic
and antiapoptotic-genes in all the tested cell lines, suggesting
a fine balance between pro- and antiapoptotic signals, both
responsible for cell-fate. The putative proapoptotic gene
BNIP3 and the closely related gene BNIP3L encode proteins
which are members of the BH3-only subfamily of Bcl-2 [46]
able to antagonise the activity of prosurvival proteins, such
as Bcl-2 [47]. Hypoxia increased BNIP3 gene expression in
all the tested cell lines and BNIP3L in HaCaT and THP-
1 (Figure 4). BNIP3 and BNIP3L have been previously
reported to promote cell death [48]. However, the con-
comitant expression of BNIP3 and BNIP3L seems critical
for autophagy induction as part of a general mechanism of
cell survival [49]. Therefore, the expression of these genes
can contribute to cell survival, through the induction of
autophagy, rather than of cell death. IGFBP3(Insulin Like
Growth Factor Binding Protein 3), which was significantly
induced in HaCaT and HMEC-1 (Figures 4(a) and 4(c)),
encodes another proapoptotic protein. Previous studies have
already shown the in vitro induction of IGFBP3mRNAunder
hypoxia in different cell lines, including HMEC-1 [50].MXI1
(MAX-interacting protein 1) which was significantly overex-
pressed in HaCaT, HDF, and THP-1 encodes an antagonist
of C-Myc, a transcription factor regulating the expression
of genes involved in cell growth and apoptosis. Increased
MXI-1 expression leads to growth arrest [51] and energy
metabolism reprogramming in cancer cells [52].The enzyme
encoded by SPHK1(sphingosine kinase 1) catalyses the phos-
phorylation of sphingosine to form sphingosine-1-phosphate.
While ceramide and sphingosine are usually proapoptotic,
sphingosine-1-phosphate stimulates growth and cell survival
[53]. Our data show that SPHK1 is downregulated in HaCaT
and HDF cells (Figures 4(a) and 4(b)).
Stress responsive proteins are usually produced to
enhance the survival of cells exposed to environmental stress,
including hypoxia.The expression of the stress-response gene
DDIT4 (DNA damage Inducible Transcript 4) is induced
by hypoxia by coactivation of HIF-1𝛼 and Sp1 [54]. Our
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data showed that it was up-regulated by hypoxia in HaCaT,
HMEC-1 and differentiated THP-1 (Figures 4(a), 4(c) and
4(d)). DDIT4 can function as a pro- or antiapoptotic factor
depending on the cellular context [55]. In HaCaT ker-
atinocytes, DDIT4 exerts an anti-apoptotic role [56], since its
downregulation is essential for apoptotic program induction,
suggesting in turn that its upregulation may protect cells
from apoptosis. Cyclin G2 is a conserved cyclin encoded by
the CCNG2 gene, which is highly expressed in the immune
system [57]. Cyclin G2 induces a p53-dependent cell cycle
arrest [58] and it is strongly upregulated during G
1
and G
2
-
phase in response to cellular stresses and growth inhibitory
signals [57]. Our data showed its induction only in THP-1 cell
lines (Figure 4(d)). NDRG1(N-myc downstream regulated
1), overexpressed in HaCaT, HMEC-1 and THP-1 cell lines
(Figures 4(a), 4(c) and 4(d)), encodes a stress responsive
protein that participate in the regulation of cellular differen-
tiation, proliferation, growth arrest, apoptosis, angiogenesis
and hypoxia sensing [59, 60]. In response to different insults,
NDRG1 expression is induced by HIF-1𝛼 [61], HIF-2𝛼 [62],
and EGR-1/SP1 [63].
Altogether, these results indicate that hypoxia induced
the expression of genes that may contribute to growth arrest
rather than to cell death, in accordance to literature data
[43].
3.5. Chemokines and Cytokines. Chemokines and cytokines
play a key role in orchestrating the multistep process of
wound healing through the regulation of angiogenesis and
the recruitment of endothelial and inflammatory cells. Few
genes encoding chemokines and cytokines were modu-
lated by 24 hours of hypoxia (Figure 5). In HaCaT, MIF
(Macrophage Migration Inhibitory Factor) was the only
up-regulated gene. The expression of this gene was also
increased in HDF and THP-1. MIF is a proinflammatory
cytokine participating in the regulation of cell proliferation
and differentiation. It is produced by a variety of cell types,
including keratinocytes, monocytes, and endothelial cells
[64, 65], and is induced by hypoxia [66], consistently with
our results. CXCL6 (C-X-C motif chemokine ligand 6) and
CXCL8 (C-X-C motif chemokine ligand 8) encode members
of CXC chemokines.These chemotactic peptides are involved
not only in leukocytesmigration, but also in angiogenesis and
inflammation. CXCL6 and CXCL8, being ERL+ chemokines,
are potent angiogenic factors [67], able to directly induce
endothelial cells migration and proliferation [68]. Here, the
expression of CXCL6 and CXCL8 was increased by hypoxia
in HMEC-1 and in THP-1 (Figures 5(c) and 5(d)). The
increased CXCL8 gene expression in HMEC-1 is consis-
tent with data from Karakurum et al. [69]but in contrast to
the effect observed by Loboda and colleagues [21]Increased
expression of CXCL8 bymouse and human macrophages has
been already described [70].
CCL2 (C-C motif chemokine ligand 2) gene encodes a
member of the CC chemokine family, also known as Mono-
cyte Chemoattractant Protein 1, able to attract macrophages.
CCL2 gene expression was down regulated by hypoxia in
HMEC-1 and THP-1 (Figures 5(c) and 5(d)). Downregulation
of CCL-2 expression by hypoxia has been previously demon-
strated in other cell types [71, 72]. This effect may suggest
a beneficial role, since a prolonged inflammatory response,
mediated by macrophages, can lead to a chronic nonhealing
wound.
TNF-𝛼 is a proinflammatory cytokine involved in the
early phases of wound healing. Macrophages may polar-
ize along proinflammatory macrophages (M1) and anti-
inflammatory macrophages (M2) [73]. In our model, TNF
gene expression was significantly downregulated in THP-
1 by hypoxia (Figure 5(d)). This may suggest that hypoxia
contribute to the differentiation of macrophages into an M2
subtype (M2d) characterized by an angiogenic phenotype
[74]. M2d macrophages express high levels of IL-10 and
VEGF and low levels of TNF-𝛼. It seems thus that hypoxia,
through the down regulation of CCL2 and TNF-𝛼, contribute
to the establishment of an anti-inflammatory environment
needed for promoting wound healing.
However, the upregulation of IFNalpha by hypoxia in
HDF may suggest a detrimental role of hypoxia in wound
healing, since IFN-alpha injection reduced healing in a
mouse model [75].
3.6. Growth Factors and Receptors. In addition to VEGFA,
several genes coding growth factors and receptors were
analysed (Figure 6). Modulation of the expression of these
genes by hypoxia was cell type-specific. Some growth factors
and receptors were up-regulated whereas others were down-
regulated by hypoxia.
FLT1 and KDR encode VEGF receptor 1 and VEGF
receptor 2, respectively. VEGFA binds both receptors, even if
all the VEGFA effects seem predominantly mediated by KDR
[76]. Moreover, FLT-1 possesses higher affinity than KDR for
VEGFA, thus acting as a decoy receptor and sequestering
VEGFA [77]. PGF (placental growth factor, a member of the
VEGF family) and VEGF-B bind FTL-1, but not KDR. Inter-
estingly, FLT1 gene expression was increased, while KDR was
decreased by hypoxia in differentiated THP-1 (Figure 6(d)).
VEGFB was also up-regulated in THP-1 suggesting that
VEGF-B could act on monocytes in an autocrine way. FLT1
was also up-regulated in HaCaT, where its ligand (PGF) was
up-regulated, too (Figure 6(a)). PGF is a potent angiogenic
factor that is induced in keratinocytes during wound healing
[78]. Here, we observed that gene expression of its receptor
(FTL1) was up- regulated not only in HaCaT but also in THP-
1 cells. PGF is a potent chemotactic factor for monocytes
that could contribute tomonocyte recruitment in the hypoxic
microenvironment of wound healing.
The expression of different genes coding for angiogenic
factors was downregulated by hypoxia. HGF (Hepatocyte
growth factor) and TYMP (Endothelial cell growth factor
1) gene expression was decreased in THP-1 and in HDF,
respectively (Figures 6(d) and 6(b)). The expression of
PDGFA (Platelet Derived Growth Factor Subunit A) and
FIGF (VEGFD) was down regulated by hypoxia in HMEC-
1 (Figure 6(c)).
Angiogenesis in wound healing is a regulated process
with a specific temporal production of different pro- and
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Figure 4: RT-qPCR analysis of genes involved in apoptosis and cell cycle after 24 hours of incubation in normoxia or hypoxia in HaCaT (a),
HDF (b), HMEC-1 (c) and THP-1 (d).The results are expressed asCt after normalization on RPLP0 housekeeping gene. Data are shown as
mean ± standard deviation and as single values distribution of four independent experiments. Circles (e) and triangles (󳶃) represent Ct
values in normoxia and hypoxia, respectively. Statistical analysis was performed using the two-tailed Student t-test comparing, for each gene,
the expression in hypoxia versus normoxia (∗p-value < 0,05; ∗∗ p-value < 0,01; ∗ ∗ ∗p-value < 0,001).
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Figure 5: RT-qPCR analysis of genes encoding cytokines and chemokines after 24 hours of incubation in normoxia or hypoxia in HaCaT (a),
HDF (b), HMEC-1 (c) and THP-1 (d).The results are expressed asCt after normalization on RPLP0 housekeeping gene. Data are shown as
mean ± standard deviation and as single values distribution of four independent experiments. Circles (e) and triangles (󳶃) represent Ct
values in normoxia and hypoxia, respectively. Statistical analysis was performed using the two-tailed Student t-test comparing, for each gene,
the expression in hypoxia versus normoxia (∗p-value < 0,05; ∗∗ p-value < 0,01).
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Figure 6: RT-qPCR analysis of genes encoding growth factors/growth factor receptors after 24 hours of incubation in normoxia or hypoxia
in HaCaT (a), HDF (b), HMEC-1 (c), and THP-1 (d). The results are expressed as Ct after normalization on RPLP0 housekeeping gene.
Data are shown as mean ± standard deviation and as single values distribution of four independent experiments. Circles (e) and triangles
(󳶃) represent Ct values in normoxia and hypoxia, respectively. Statistical analysis was performed using the two-tailed Student’s t-test
comparing, for each gene, the expression in hypoxia versus normoxia (∗p-value < 0,05; ∗∗ p-value < 0,01; ∗ ∗ ∗p-value < 0,001).
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Figure 7: RT-qPCR analysis of genes involved in coagulation after 24 hours of incubation in normoxia or hypoxia in HaCaT (a), HDF (b),
HMEC-1 (c), and THP-1 (d). The results are expressed as Ct after normalization on RPLP0 housekeeping gene. Data are shown as mean
± standard deviation and as single values distribution of four independent experiments. Circles (e) and triangles (󳶃) represent Ct values
in normoxia and hypoxia, respectively. Statistical analysis was performed using the two-tailed Student t-test comparing, for each gene, the
expression in hypoxia versus normoxia (∗p-value < 0,05; ∗∗ p-value < 0,01; ∗ ∗ ∗p-value < 0,001).
antiangiogenic factors. Our data suggest that hypoxia can
differently induce or decrease the production of these factors
in a cell-specific way.
3.7. Coagulation. Since both anti- and procoagulant factors
are transcriptional targets of HIF-1 [79], some genes involved
in coagulation were analysed. PTGS1 (Prostaglandin-
endoperoxide synthase 1), whose expression was increased
by hypoxia in HMEC-1 and THP-1 (Figures 7(c) and
7(d)), encodes the constitutive isoform of cyclooxygenase
that catalyses the conversion of the arachidonic acid
into prostaglandins. In particular, this isoform generates
prostaglandin E
2
and prostaglandin D
2
, which are not only
important for vascular homeostasis, but also for inducing
the expression of some growth factors of the VEGFs family,
promoting new vessels formation during skin repair [80, 81].
PLAU encodes urokinase plasminogen activator (uPA),
which cleaves plasminogen into plasmin. SERPINE1 (Serpin
family Emember 1) encodes Plasminogen activator inhibitor-
1 (PAI-1), a serine proteinase inhibitor of uPA and tissue
plasminogen activator (tPA). Both uPA and PAI-1 play a
key role in coagulation and tissue remodeling. PAI-1 and
uPA are usually secreted by several cell types including
endothelial cells, macrophages and fibroblasts. Previous stud-
ies have shown that hypoxia up-regulates PAI-1, whereas it
downregulates uPA [82, 83]. Here, SERPINE1 gene expres-
sion was significantly up-regulated by hypoxia in HaCaT,
HMEC-1 and differentiated THP-1 (Figures 7(a), 7(c), and
7(d)) whereas PLAU was downregulated in HDF and THP-
1 (Figures 7(b) and 7(d)).The fine balance between PAI-1 and
uPA is required for efficient tissue repair. In chronic wounds
the excessive secretion of PAI-1 leads to the inhibition of uPA
with the subsequent formation of fibrotic tissue [84].
3.8. Transcription and Signaling. Since the adaptive response
to hypoxia allows for the transcriptional activation of mul-
tiple genes, five genes encoding transcription factors or
molecules which interact with transcription factors were
included in the analysis (Figure 8).
ANKRD37 (Ankyrin repeat domain 37) and BHLHE40
(Basic helix-loop-helix family member e40) were up-
regulated in all the cell types analysed. ANKRD37 encodes
a short protein with unknown function but characterised
by ankyrin repeats, which are known to be involved in
the regulation of the activity of transcription factors such
as NF-𝜅B and p53 [85]. ANKRD37is known as a target of
HIF-1 in different cell lines [86]. Since it was significantly
induced in all cell lines tested in this work (Figure 8), it
is likely to have an important role in the transcriptional
program induced by hypoxia in the skin. This may be true
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Figure 8: RT-qPCR analysis of genes involved in transcription and signaling after 24 hours of incubation in normoxia or hypoxia in HaCaT
(a),HDF (b),HMEC-1 (c) andTHP-1 (d).The results are expressed asCt after normalization on RPLP0 housekeeping gene.Data are shown
asmean ± standard deviation and as single values distribution of four independent experiments. Circles (e) and triangles (󳶃) representCt
values in normoxia and hypoxia, respectively. Statistical analysis was performed using the two-tailed Student’s t-test comparing, for each gene,
the expression in hypoxia versus normoxia (∗p-value < 0,05; ∗∗ p-value < 0,01; ∗ ∗ ∗p-value < 0,001).
also for BHLHE40(DEC1), which encodes a transcriptional
repressor involved in adaptation to hypoxia [87]. Differently
from ANKRD37, the induction of BHLHE40 in response
to hypoxia occurs through a p53-dependent mechanism,
independent from HIF1-𝛼. Since BHLHE40 may contribute
to muscle regeneration after ischemia [88], a role also in skin
wound healing is plausible.
Two genes are strictly connected with HIF activity:
EGLN1 and HIF3A. EGLN1 encodes PHD2, one of the three
isoforms of human prolyl hydroxylases. Prolyl hydroxylation
is a critical event to initiate oxygen-dependent degradation
of HIF1-𝛼 in normoxia. PHD2 regulates the homeostatic
levels of HIF-1𝛼 and is a cellular oxygen sensor [89, 90].
EGLN1 was significantly up-regulated only in HaCaT (Fig-
ure 8(a)). HIF3A encodes HIF-3𝛼, a transcription factor
which is related to HIF-1𝛼 both structurally and for common
responsive elements [91]. In contrast to the ubiquitarian HIF-
1𝛼, HIF-3𝛼 appears to be expressed in a cell type-specific
manner. Our data show that HIF3Awas not expressed in
HaCaT and differentiated THP-1, and it was significantly
upregulated in HDF cells only (Figure 8(b)), in accordance
with previous works [92].
ID1 (inhibitor of DNA-binding type 1) encodes a member
of helix-loop-helix (HLH) proteins and inhibits the tran-
scription activity of other HLH proteins [93]. ID1, which
favours cell migration and proliferation, is up-regulated upon
skin injury and downregulated during wound repair [94,
95]. However, in the tested cell types, including HaCaT ker-
atinocytes, ID1 was not significantly modulated by hypoxia.
This supports that ID1 modulation requires interaction
between cells, as previously described [94, 95].
3.9. Glycolytic Metabolism. Under hypoxia glycolysis is
enhanced and may function as a compensatory mechanism
for ensuring enough generation of ATP. Moreover, enhanced
glycolysis leads to the increase of the end-product lactic acid,
which promotes angiogenesis, enhances collagen deposition
and accelerates wound healing [96, 97]. The genes encoding
the enzymes involved in glycolysis are indeed upregulated,
through HIF-1𝛼 stabilization [98]. The hypoxia-responsive
genes controlling the shift from mitochondrial oxidative
phosphorylation to glycolytic metabolism are expected to
be shared by different cell populations. Yet, our data show
some differences in gene expression in the different cell types.
All the 13 genes considered in this study were significantly
increased in HaCaT keratinocytes (Figure 9(a)). Ten and
9 genes were upregulated in HDF and THP-1 respectively
(Figures 9(b) and 9(d)), while the expression of 4 genes was
increased in HMEC-1 (Figure 9(c)). The gene encoding hex-
okinases 2 (HK2), an important enzyme responsible for the
catalysis of the first step of the glycolytic pathway, that is the
phosphorylation of glucose into glucose-6-phosphate, was
significantly increased by hypoxia in all the tested cell lines
(Figure 9). This result was expected, since HK2 is encoded
by a HIF-1 target gene, unlike other HK isoforms [99].
GPI (Glucose-6-phosphate isomerase) encodes the glycolytic
enzyme that interconverts glucose-6-phosphate and fructose-
6-phosphate. Extracellularly, the encoded protein functions
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Figure 9: RT-qPCR analysis of genes involved in glycolytic metabolism after 24 hours of incubation in normoxia or hypoxia in HaCaT (a),
HDF (b), HMEC-1 (c) and THP-1 (d).The results are expressed asCt after normalization on RPLP0 housekeeping gene. Data are shown as
mean ± standard deviation and as single values distribution of four independent experiments. Circles (e) and triangles (󳶃) represent Ct
values in normoxia and hypoxia, respectively. Statistical analysis was performed using the two-tailed Student’s t-test comparing, for each gene,
the expression in hypoxia versus normoxia (∗p-value < 0,05; ∗∗ p-value < 0,01; ∗ ∗ ∗p-value < 0,001).
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as a lymphokine and angiogenic factor [100]. GPI expression
was significantly increased in all the cell types except HMEC-
1 (Figure 9). PFKP (Phosphofructokinase), which encodes
the enzyme that converts fructose 6-phosphate (Fru-6-P)
into fructose 1,6-bisphosphate was significantly increased in
HaCaT and HDF (Figures 9(a) and 9(b)). PFKP activity
is regulated by the energetic status of the cell through the
inhibitory effect of ATP, that limits glycolysis under aerobic
conditions, and by the allosteric activation by fructose-2,6-
bisphosphate (Fru-2,6-P
2
) [101, 102]. The synthesis of Fru-
2,6-P
2
from Fru-6-P is catalyzed by the proteins encoded by
PFKFB3 and PFKFB4 genes, which are induced by hypoxia
via HIF-1𝛼 activation, as demonstrated by the discovery of
HIF-1-binding sites within their promoters [103, 104]. These
enzymes are known as 6-phosphofructo-2-kinase/fructose-
2,6-bisphosphatase, which catalyse not only the synthesis but
also the degradation of the glycolytic by-product Fru-2,6-
P
2
. PFKFB3 shows the highest kinase/phosphatase activity
ratio [105], thus enhancing glycolysis. Our data showed
that PFKFB3was significantly up-regulated only in HaCaT
cells (Figure 9(a)), opposite to PFKFB4 which was induced
in all the cell lines but HMEC-1. The protein encoded by
PGK1 (phosphoglycerate kinase 1) is a glycolytic enzyme that
catalyses the conversion of 1,3-diphosphoglycerate into 3-
phosphoglycerate, coupled with the synthesis of ATP from
ADP. PGK1 is a HIF1𝛼 target gene that can phosphorylate
pyruvate dehydrogenase kinase 1 (PDK1), leading to inhibi-
tion of mitochondrial metabolism and improvement of gly-
colysis. During hypoxia, PGK1 is also involved in regulation
of autophagy [106]. Here, PGK1 gene expression was induced
in HaCaT and HDF (Figures 9(a) and 9(b)), while PDK1 was
upregulated in HaCaT, HDF and THP-1 (Figures 9(a), 9(b)
and 9(d)). PDK1 plays an important role also in proliferation,
since it protects cells against apoptosis in response to hypoxia
and oxidative stress, weakening the activity of respiratory
chain [107]. LDH (Lactate dehydrogenase) is a tetrameric
enzyme composed by four subunits, the two most common
of which are LDH-H, encoded by the LDHB gene, and LDH-
M, encoded by the HIF-1 target gene LDHA and therefore
induced under hypoxia. Compared to LDH-H, LDH-M
preferentially catalyses the reduction of pyruvate into lactate
[108], showing a pivotal role in sustaining high glycolytic
flux and counteracting apoptosis. The increase of LDHA
expression occurs in tandem with the inhibition of pyruvate
dehydrogenase mediated by PDK1, diverting pyruvate from
the tricarboxylic acid cycle. The conversion of pyruvate into
lactate couples at the same time the oxidation of NADH
to NAD+, restoring the pool required for glycolytic auto-
sufficiencywhenoxygen becomes a limiting factor.Moreover,
the resulting low levels of pyruvate enable cells relying on
glycolysis to evade cell death [109]. LDHA was significantly
up-regulated in HaCaT, HMEC-1 and HDF (Figures 9(a),
9(b), and 9(c)).
SLC2A3(Solute Carrier Family 2 Member 3), which was
significantly induced in HaCaT, HMEC-1 and THP-1 cells
(Figures 9(a), 9(b), and 9(c)), encodes Glucose transporter
3 (GLUT3), responsible for facilitating the diffusion of
monosaccharides, in particular glucose, across the plasma
membrane. The HIF-1-dependent expression of GLUT3 [110]
plays an important role in ensuring efficient glucose uptake,
even when glucose becomes a limiting factor [111], thus
accomplishing the glycolytic switch seen under hypoxic
conditions.
3.10. Nonglycolytic Metabolism. CA9 encodes carbonic
anhydrase 9, a transmembrane member of the zinc-
metalloenzyme family that catalyses the reversible
hydration of CO
2
, thus being involved in the regulation
of pH homeostasis [112]. Due to the Hypoxia Response
Elements (HREs) identified in its promoter, it is one
of the most sensitive endogenous sensors of HIF-1𝛼
activity [113] and it has been proposed as an endogenous
biomarker of cellular hypoxia in HMEC-1 [114]. Our data
showed its significant induction in HaCaT, HDF and
HMEC-1 (Figure 10). ERO1L (Endoplasmic reticulum
oxidoreductase 1 alpha) encodes an endoplasmic reticulum
membrane-associated oxidoreductase involved in disulphide
bond formation [115], crucial for the proper folding of
proteins. ERO1L appears to be upregulated by hypoxia and
involved in VEGF secretion [116]. ERO1L expression was
significantly increased by hypoxia in HaCaT and THP-1
(Figures 10(a) and 10(d)).
Glycogen accumulation under hypoxic conditions seems
to be an emergingmetabolic survival pathway.Many cell lines
contain a detectable amount of glycogen under normoxic
culture conditions [117] and hypoxia induces accumula-
tion of glycogen. Glycogen synthase 1 (GYS1) is respon-
sible for the addition of glucose monomers to the grow-
ing glycogen molecule, whereas 1,4-𝛼 glucan branching
enzyme 1 (GBE1) is responsible for the addition of branches.
Their up-regulation during hypoxia is mediated by HIF-1
and induce glycogen accumulation [118]. In our cell lines,
GBE1 was up-regulated in HaCaT and in differentiated
THP-1 while GYS1 was up-regulated in HaCaT and HDF
(Figure 10).
MCT4 protein, encoded by SLC16A3 (Solute carrier
family 16 member 3), is a member of the monocarboxylate
transporter family, which catalyses the bidirectional trans-
port of short-chain monocarboxylates, such as L-lactate,
pyruvate and ketone bodies, across the cell membrane.MCT4
is significantly expressed in hypoxic tissues, which depend
on glycolysis for ATP production, and mediates the efflux of
lactic acid from cells [119]. The expression of SLC16A3 is up-
regulated in response to hypoxia, through HIF-1-enhanced
gene transcription [119]. In our model, SLC16A3 was signif-
icantly overexpressed by hypoxia in HDF and differentiated
THP-1 (Figures 10(b) and 10(d)).
4. Conclusions
In this work, the changes in gene expression in response
to hypoxic condition in cell populations involved in wound
healing have been described. Under hypoxia, cells undergo
a variety of biological modifications which can be different
depending on the cell types, their function and energy
requirements.
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Figure 10: RT-qPCR analysis of genes involved in nonglycolytic metabolism after 24 hours of incubation in normoxia or hypoxia in HaCaT
(a),HDF (b),HMEC-1 (c), andTHP-1 (d).The results are expressed asCt after normalization onRPLP0 housekeeping gene.Data are shown
asmean ± standard deviation and as single values distribution of four independent experiments. Circles (e) and triangles (󳶃) representCt
values in normoxia and hypoxia, respectively. Statistical analysis was performed using the two-tailed Student t-test comparing, for each gene,
the expression in hypoxia versus normoxia (∗p-value < 0,05; ∗∗ p-value < 0,01; ∗ ∗ ∗p-value < 0,001).
Exposure of different cell types to hypoxia revealed dis-
tinctive results, showing a higher number of genes modulated
in HaCaT and differentiated THP-1 and a lower number of
genes modulated in HDF and HMEC-1 (Figure 11). In HaCat
and HDF, most of the modulated genes belong to the class
of glycolytic metabolism. In these cell types, hypoxia mostly
induce the expression of genes needed for reprogramming
cells from oxidative to glycolytic metabolism. Differently, in
HMEC-1 the highest number of genes modulated by hypoxia
encode proteins involved in angiogenesis. It seems that
during hypoxia autocrine signals are required for sustaining
angiogenesis by endothelial cells. A high number of genes
encoding proteins involved in angiogenesis were also up-
regulated in differentiated THP-1. This is not unexpected,
since macrophages are known to play a crucial role in the
modulation of angiogenesis by the production of secreted
molecules. Genes coding for cytokines/chemokines and
growth factor were also mostly modulated in differentiated
THP-1 and in HMEC-1. However, VEGF-A gene expression
was increased in all the cells type involved in wound healing,
indicating that this essential growth factor is induced by
hypoxia in aspecific way.
Hypoxia has a key role in wound healing. Knowing which
genes are modulated by hypoxia in cell populations involved
in skin repair may be useful to start deeper investigations on
the underlying mechanisms.
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Figure 11: Volcano plot of the gene expression profiles and pie chart.The gene expression profiles was evaluated after 24 hours of incubation in
normoxia or hypoxia in HaCaT (a), HDF (b), HMEC-1 (c) and THP-1 (d). In Volcano Plots each point represents the difference in expression
between normoxia and hypoxia against the level of significance. The x-axis specifies the ΔΔCt and the y-axis specifies the negative logarithm
to the base 10 of the t-test p-values. The horizontal dotted line reflects the filtering criteria (p-value = 0.05). Pie charts indicate the numerical
proportion of each set of genes whose expression was modulated in hypoxia.
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